Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Alopecia can be caused by multicentric reticulohistiocytosis.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Sexual dysfunction is common in autoimmune rheumatic diseases but often overlooked and needs better attention in care.

JAK inhibitors may help improve symptoms in adults with APECED.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hyaluronic acid injections can cause serious artery blockages, so practitioners must be careful.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

The document discusses a special exam case for formulating and using systemic therapy named Athena.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Axolotl-derived skin scaffolds may help heal wounds better by reducing scarring.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Targeting the AhR pathway may help treat alopecia areata.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

DM and AA may share a common cause.